To ensure a level playing field for all investors, including the ones that don't use Twitter, I think the following Tweet should also be mentioned here:
"Dr Madison Paton on Cynata's MSCs" as part of the Neonatal Regenerative Therapies session on 2nd September 2022 at the Australasian Brain Club.
This is the current feeling of a Cynata investor:
Lets try and fix that.
It all starts with our failed MEND trial and the original contact details:
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=379838&showHistory=true&isReview=true
About Dr Paton:
https://cerebralpalsy.org.au/sstposts/StoryId1657069276295
Why would the Cerebral Palsy Alliance have an interest to support this:
[...]
https://www.ahajournals.org/doi/10.1161/STR.0000000000000183
It seems that Dr Paton is pitching the use of Cymerus MSCs to establish Australia's first mesenchymal stem cell (MSC) therapy clinical trial for newborn stroke.
Fixed. A level playing field for all Cynata investors.
Maybe there's something good coming out of our MEND trial after all, even if it's only the connections made.
To ensure a level playing field for all investors, including the...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $45.11M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.5¢ | 18.5¢ | $92.99K | 484.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 91722 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 120294 | 2 |
View Market Depth
| Last trade - 16.10pm 18/09/2025 (20 minute delay) ? |
| CYP (ASX) Chart |